Katja Sockel

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Uwe Platzbecker, Jan Moritz Middeke, Katja Sockel et al. · The Lancet Oncology · 2018 · 354 citations

Medicine, Hematology, Pharmacology +17

<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

Franziska Taube, Julia Annabell Georgi, Michael Krämer et al. · Blood · 2021 · 164 citations · Full text

Medicine, Genetics, Molecular Genetics +8

Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

Jan‐Niklas Eckardt, Jan Moritz Middeke, Sebastian Riechert et al. · Leukemia · 2021 · 119 citations · Full text

Computing, Computer Science, Hematology +12

CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease

Judith S. Hecker, Luise Hartmann, Jennifer Rivière et al. · Blood · 2021 · 97 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11